🌐 WorldLive

Kahimmune Therapeutics signs exclusive licensing agreement with Gustave Roussy and SATT Paris-Saclay

📅 02/02/2026 06:25 📰 menafn 👁️ 0 lectures 🌍 Royaume-Uni 📂 Santé
Kahimmune Therapeutics signs exclusive licensing agreement with Gustave Roussy and SATT Paris-Saclay

(MENAFN - ALA Group) –Newly created spin-off of Gustave Roussy and SATT Paris-Saclay specializing in immuno-oncology will exploit hidden genome, also known as dark genome or non-coding genome –It ...

📖 Lire l'article complet

Cet article provient de menafn

Lire sur le site source →
← Retour à l'accueil Plus d'articles Santé

📰 Articles similaires

CalMac's newest ferry Isle of Islay stormbound off Morocco on 3,000-mile voyage home

CalMac's newest ferry Isle of Islay stormbound off Morocco on 3,000-mile voyage home

 Skin cream containing 'excess of Mercury' urgently recalled over health fears

Skin cream containing 'excess of Mercury' urgently recalled over health fears

 Huge spike in Norovirus cases in the North West - here's the simple thing you can do to prevent illness

Huge spike in Norovirus cases in the North West - here's the simple thing you can do to prevent illn

 Huge spike in Norovirus cases in the North West - here's the simple thing you can do to prevent illness

Huge spike in Norovirus cases in the North West - here's the simple thing you can do to prevent illn

 Huge spike in Norovirus cases in the North West - here's the simple thing you can do to prevent illness

Huge spike in Norovirus cases in the North West - here's the simple thing you can do to prevent illn